Colorectal cancer is the third most common and second most deadly cancer in the world. Its early detection significantly increases the patient's chances of recovery.

At Medicover Hospital we perform COLOTECT™ 1.0 - a non-invasive test for colorectal cancer. This is the first 3-marker non-invasive epigenetic test that can detect colorectal lesions at an early stage of development. This is particularly important as this type of cancer may not cause symptoms until later stages of the disease, when many patients have already metastasised – this is why screening is essential. 

Buy online

 

Advantages of the COLOTECT Test:

  • Non-invasive diagnostic method – just a stool sample taken at home.
  • High test sensitivity of 96% and specificity of 92%, detecting precancerous lesions with a sensitivity of 52%.
  • No preparation required (no need for any special diet, no need to change medications).
  • Early detection of benign lesions allows prompt treatment and reduces the risk of developing cancer.

At Medicover Hospital, we offer diagnostic packages consisting of the COLOTECT test and a medical consultation to discuss the results.

Contact us to learn more about our offer and get more details
Call 500 900 900
or fill in the form – and we will call you back.

Szpital Medicover
Aleja Rzeczypospolitej 5
02-972 Warszawa